Personalized nutrition to lower blood pressure — Chicago
Nutrition Precision Health for All of Us (Chicago Center)
This program uses detailed biological testing and remote monitoring to personalize diets to help people with high blood pressure lower their blood pressure.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11248319 on NIH RePORTER |
What this research studies
If you join through the Northwestern/Chicago All of Us site, you would follow three short diet modules that include parts of the DASH diet while your blood pressure is tracked. You would provide biosamples (blood or other specimens) and wear remote devices or complete real-time diet reporting so researchers can do high-throughput 'omic' testing and capture daily responses. The team will combine your genetic, molecular, and behavioral data to see who responds best to specific dietary elements. The goal is to create more tailored nutrition advice based on how individual bodies actually react.
Who could benefit from this research
Good fit: Adults enrolled in or willing to join the All of Us Research Program, especially those with hypertension or at higher risk who can follow diet modules and provide biosamples and remote data, are ideal candidates.
Not a fit: People not enrolled in All of Us, unwilling or unable to make dietary changes or provide samples and remote data, or whose blood pressure is controlled solely by medications may not benefit from this nutrition-focused approach.
Why it matters
Potential benefit: Could lead to personalized diet recommendations that lower blood pressure and reduce the risk of heart, stroke, and kidney disease for people who respond.
How similar studies have performed: The DASH diet has strong evidence for lowering blood pressure, but combining omics and remote monitoring to personalize responses is a newer approach with limited prior clinical results.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Van Horn, Linda Verner — Northwestern University
- Study coordinator: Van Horn, Linda Verner
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.